Literature DB >> 20738853

Skin cancers in albinos in a teaching Hospital in eastern Nigeria - presentation and challenges of care.

Kingsley O Opara1, Bernard C Jiburum.   

Abstract

BACKGROUND: Albinism is a genetic disorder characterized by lack of skin pigmentation. It has a worldwide distribution but is commoner in areas close to the equator like Nigeria. Skin cancers are a major risk associated with albinism and are thought to be a major cause of death in African albinos. Challenges faced in the care of these patients need to be highlighted in order to develop a holistic management approach with a significant public health impact. The aim of the study was to determine the pattern of skin cancers seen in Albinos, and to highlight problems encountered in their management.
METHOD: Case records of albinos managed in Imo state University teaching Hospital from June 2007 to May 2009 were reviewed. The data obtained was analyzed using descriptive statistics. RESULTS AND DISCUSSION: In the period under review, albinos accounted for 67% of patients managed for primary skin cancers. There were twenty patients with thirty eight (38) lesions. Sixty one percent of the patients were below 40 years. Average duration of symptoms at presentation was 26 months. The commonest reason for late presentation was the lack of funds. Squamous cell carcinoma was the commonest histologic variant. Most patients were unable to complete treatment due to lack of funds.
CONCLUSION: Albinism appears to be the most important risk factor in the development of skin cancers in our environment. Late presentation and poor rate of completion of treatment due to poverty are major challenges.

Entities:  

Mesh:

Year:  2010        PMID: 20738853      PMCID: PMC2936286          DOI: 10.1186/1477-7819-8-73

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  16 in total

Review 1.  The actinic (solar) keratosis: a 21st-century perspective.

Authors:  Wendy Fu; Clay J Cockerell
Journal:  Arch Dermatol       Date:  2003-01

2.  Albinism and skin cancer in Southern Africa.

Authors:  J G Kromberg; D Castle; E M Zwane; T Jenkins
Journal:  Clin Genet       Date:  1989-07       Impact factor: 4.438

3.  Advanced skin cancer in Tanzanian albinos: preliminary observations.

Authors:  G A Alexander; U K Henschke
Journal:  J Natl Med Assoc       Date:  1981-11       Impact factor: 1.798

Review 4.  The epidemiology of skin cancer.

Authors:  Thomas L Diepgen; V Mahler
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302

5.  Albinism in Nigeria. A clinical and social study.

Authors:  A N Okoro
Journal:  Br J Dermatol       Date:  1975-05       Impact factor: 9.302

6.  The Tanzanian human albino skin. Natural history.

Authors:  J Luande; C I Henschke; N Mohammed
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

Review 7.  Incidence of nonmelanoma skin cancer.

Authors:  F Urbach
Journal:  Dermatol Clin       Date:  1991-10       Impact factor: 3.478

Review 8.  Sun exposure and non-melanocytic skin cancer.

Authors:  A Kricker; B K Armstrong; D R English
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

9.  Cutaneous cancers in Calabar, Southern Nigeria.

Authors:  Maurice E Asuquo; Godwin Ebughe
Journal:  Dermatol Online J       Date:  2009-04-15

10.  Skin cancer in the South African Bantu.

Authors:  M P SHAPIRO; P KEEN; L COHEN; J F MURRAY
Journal:  Br J Cancer       Date:  1953-03       Impact factor: 7.640

View more
  16 in total

1.  Analysis of MC1R variants in Indian oculocutaneous albinism patients: highlighting the risk of skin cancer among albinos.

Authors:  Mainak Sengupta; Devroop Sarkar; Maitreye Mondal; Swapan Samanta; Asim Sil; Kunal Ray
Journal:  J Genet       Date:  2013       Impact factor: 1.166

2.  Neoadjuvant chemotherapy in Albinos with locally advanced skin cancer at a Blantyre Hospital: - Case Series.

Authors:  I A Chidothe; L Masamba
Journal:  Malawi Med J       Date:  2014-09       Impact factor: 0.875

Review 3.  Was skin cancer a selective force for black pigmentation in early hominin evolution?

Authors:  Mel Greaves
Journal:  Proc Biol Sci       Date:  2014-02-26       Impact factor: 5.349

4.  Skin cancers among Albinos at a University teaching hospital in Northwestern Tanzania: a retrospective review of 64 cases.

Authors:  Joseph B Mabula; Phillipo L Chalya; Mabula D Mchembe; Hyasinta Jaka; Geofrey Giiti; Peter Rambau; Nestory Masalu; Erasmus Kamugisha; Ssentongo Robert; Japhet M Gilyoma
Journal:  BMC Dermatol       Date:  2012-06-08

5.  Common malignant cutaneous conditions among albinos in Kenya.

Authors:  Seyed Emad Emadi; Andrew Juma Suleh; Farhang Babamahmoodi; Fatemeh Ahangarkani; Vanessa Betty Chelimo; Beatrice Mutai; Seyyed Reza Raeeskarami; Alireza Ghanadan; Seyed Naser Emadi
Journal:  Med J Islam Repub Iran       Date:  2017-01-11

6.  Multiple Basal Cell Carcinomas in a Patient of Oculocutaneous Albinism.

Authors:  Debasmita Behera; Tapaswini Tripathy; Bikash R Kar
Journal:  Indian Dermatol Online J       Date:  2017 Mar-Apr

Review 7.  Oculocutaneous Albinism and Squamous Cell Carcinoma of the Skin of the Head and Neck in Sub-Saharan Africa.

Authors:  P T Lekalakala; R A G Khammissa; B Kramer; O A Ayo-Yusuf; J Lemmer; L Feller
Journal:  J Skin Cancer       Date:  2015-08-12

Review 8.  Histological review of skin cancers in African Albinos: a 10-year retrospective review.

Authors:  Samson Kimaiyo Kiprono; Baraka Michael Chaula; Helmut Beltraminelli
Journal:  BMC Cancer       Date:  2014-03-06       Impact factor: 4.430

9.  A partial gene deletion of SLC45A2 causes oculocutaneous albinism in Doberman pinscher dogs.

Authors:  Paige A Winkler; Kara R Gornik; David T Ramsey; Richard R Dubielzig; Patrick J Venta; Simon M Petersen-Jones; Joshua T Bartoe
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

10.  Cutaneous Cancers in Nigerian Albinos: A Review of 22 Cases.

Authors:  Oluwafemi Olasupo Awe; Terence Akhator Azeke
Journal:  Niger J Surg       Date:  2018 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.